Published in Lab Business Week, November 22nd, 2009
"Year-over-year increases in operating income, cash and deferred revenue demonstrate another solid financial quarter for our business," said Max Carnecchia, President and Chief Executive Officer of Accelrys. "From an operating standpoint, we are also pleased with our performance. We recently had a successful European User Group meeting and continued to innovate on the product front with the announced release of our Materials Studio 5.0 software suite. We also further validated our value to science-based companies outside the pharmaceutical industry by entering into an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week